Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 43Head and Neck Neoplasms 35Nasopharyngeal Carcinoma 19Oropharyngeal Neoplasms 17Carcinoma, Squamous Cell 15Rectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 11Esophageal Squamous Cell Carcinoma 11Mouth Neoplasms 8Esophageal Neoplasms 8Pancreatic Neoplasms 7Laryngeal Neoplasms 7Sarcoma 6Tongue Neoplasms 5Papillomavirus Infections 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Glioblastoma 5Brain Neoplasms 5Stomatitis 4Neoplasm Metastasis 4Nasopharyngeal Neoplasms 4Carcinoma 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Thyroid Carcinoma, Anaplastic 3Lymphatic Metastasis 3Gliosarcoma 3Glioma 3

Interventions

Gemcitabine 26Capecitabine 16Oxaliplatin 14Fluorouracil 13Cisplatin 12Leucovorin 9pembrolizumab 5Erlotinib Hydrochloride 5Bevacizumab 5durvalumab 4Trastuzumab 4Specimen Handling 4Sorafenib 4Magnetic Resonance Spectroscopy 4130-nm albumin-bound paclitaxel 4trifluridine tipiracil drug combination 3Lapatinib 3Irinotecan 3Carboplatin 3Biopsy 3tremelimumab 2toripalimab 2regorafenib 2lenvatinib 2dehydroftorafur 2cobimetinib 2atezolizumab 2anlotinib 2Nivolumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gallbladder Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡